US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist

2.8500
-0.0900-3.06%

Close Feb 14 16:00 ET

3.0100
+0.1600+5.61%

Post 20:01 ET

48.21MMarket Cap-1.35P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NRX Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 5.000M	--
--	2024/Q4	-- / 0.000	--
Nov 18, 2024	2024/Q3	0.000 / 0.000	--
Aug 14, 2024	2024/Q2	0.000 / 0.000	--
May 14, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 5.000M--

--2024/Q4-- / 0.000--

Nov 18, 20242024/Q30.000 / 0.000--

Aug 14, 20242024/Q20.000 / 0.000--

May 14, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

NRX Pharmaceuticals Earnings Reports

8-K: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update

Nov 15, 2024 17:29 ET

10-Q: Q3 2024 Earnings Report

Nov 14, 2024 17:14 ET

8-K: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update

Aug 15, 2024 13:14 ET

10-Q: Q2 2024 Earnings Report

Aug 14, 2024 16:44 ET